{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T18:14:20Z","timestamp":1775758460235,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1822-1","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T08:03:23Z","timestamp":1548317003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher\/European Scleroderma Trials and Research group (EUSTAR) survey"],"prefix":"10.1186","volume":"21","author":[{"name":"EUSTAR co-workers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Blagojevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bellando-Randone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Abignano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Avouac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cometi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Czirj\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. P.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Distler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Frerix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Guiducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Huscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. K.","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"L\u00f3r\u00e1nd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Nihtyanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Riemekasten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Siegert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. H.","family":"Tarner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vettori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U. A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Del Galdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"1822_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5301\/jsrd.5000249","volume":"2","author":"J Varga","year":"2017","unstructured":"Varga J, Trojanowska M, Kuwana M. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Relat Disord. 2017;2:137\u201352.","journal-title":"J Scleroderma Relat Disord"},{"key":"1822_CR2","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/art.37988","volume":"65","author":"M Matucci-Cerinic","year":"2013","unstructured":"Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum. 2013;65:1953\u201362.","journal-title":"Arthritis Rheum"},{"key":"1822_CR3","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1136\/annrheumdis-2015-208121","volume":"75","author":"M Matucci-Cerinic","year":"2016","unstructured":"Matucci-Cerinic M, Krieg T, Guillevin L, Schwierin B, Rosenberg D, Cornelisse P, et al. Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry. Ann Rheum Dis. 2016;75:1770\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1822_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/annrheumdis-2014-205897","volume":"75","author":"C Mihai","year":"2016","unstructured":"Mihai C, Landew\u00e9 R, van der Heijde D, Walker UA, Constantin PI, Gherghe AM, et al. Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis. 2016;75:681\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1822_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/rheumatology\/kex182","volume":"57","author":"VK Jaeger","year":"2018","unstructured":"Jaeger VK, Distler O, Maurer B, Czirj\u00e1k L, L\u00f3r\u00e1nd V, Valentini G, et al. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford). 2018;57:441\u201350.","journal-title":"Rheumatology (Oxford)"},{"key":"1822_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5301\/jsrd.5000238","volume":"2","author":"W Li","year":"2017","unstructured":"Li W, Frech TM. The critical need for accurately defining digital ulcers in scleroderma (editorial). J scleroderma Relat Disord. 2017;2:69\u201371.","journal-title":"J scleroderma Relat Disord"},{"key":"1822_CR7","doi-asserted-by":"crossref","unstructured":"Suliman YA, Bruni C, Johnson S, Praino E, Alemam A, Borazan N, et al. Defining skin ulcers in systemic sclerosis: systematic literature review and proposed World Scleroderma Foundation definition. J Scleroderma Relat Disord. 2017;2:115\u201320.","DOI":"10.5301\/jsrd.5000236"},{"key":"1822_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5301\/jsrd.5000203","volume":"1","author":"Y Suliman","year":"2016","unstructured":"Suliman Y, Ranganath V, Fitzgerald J, Elashoff D, Jackson N, Kafaja S, et al. Preliminary musculoskeletal ultrasound ulcer definition does not correlate with visual observation in systemic sclerosis patients. (abstract). J Scleroderma Relat Disord. 2016;1:43\u2013169.","journal-title":"J Scleroderma Relat Disord"},{"key":"1822_CR9","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/rheumatology\/keq097","volume":"49","author":"L Amanzi","year":"2010","unstructured":"Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S, et al. Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford). 2010;49:1374\u201382.","journal-title":"Rheumatology (Oxford)"},{"key":"1822_CR10","unstructured":"https:\/\/www.unigiessen.de\/faculties\/f11\/facilities\/desscipher-en?set_language=en\n                    \n                  . Accessed 30 July 2018."},{"key":"1822_CR11","unstructured":"www.eustar-online.org\n                    \n                  . Accessed 30 July 2018."},{"key":"1822_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"Walker UA, Tyndall A, Czirj\u00e1k L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis. 2007;66:754\u201363.","journal-title":"Ann Rheum Dis"},{"key":"1822_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jbi.2014.12.002","volume":"54","author":"RR Kelley","year":"2015","unstructured":"Kelley RR, Mattingly WA, Wiemken TL, Khan M, Coats D, Curran D, et al. Visual grids for managing data completeness in clinical research datasets. J Biomed Inform. 2015;54:337\u201344.","journal-title":"J Biomed Inform"},{"key":"1822_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/rheumatology\/keu296","volume":"54","author":"C Bruni","year":"2015","unstructured":"Bruni C, Guiducci S, Bellando-Randone S, Lepri G, Braschi F, Fiori G, et al. Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis. Rheumatology (Oxford). 2015;54:72\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"1822_CR15","first-page":"S47","volume":"33","author":"M Brand","year":"2015","unstructured":"Brand M, Hollaender R, Rosenberg D, Scott M, Hunsche E, Tyndall A, et al. An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database. Clin Exp Rheumatol. 2015;33:S47\u201354.","journal-title":"Clin Exp Rheumatol"},{"key":"1822_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10067-012-2161-7","volume":"32","author":"D Giuggioli","year":"2013","unstructured":"Giuggioli D, Manfredi A, Colaci M, Lumetti F, Ferri C. Osteomyelitis complicating scleroderma digital ulcers. Clin Rheumatol. 2013;32:623\u20137.","journal-title":"Clin Rheumatol"},{"key":"1822_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/acr.20673","volume":"64","author":"D Giuggioli","year":"2012","unstructured":"Giuggioli D, Manfredi A, Colaci M, Lumetti F, Ferri C. Scleroderma digital ulcers complicated by infection with fecal pathogens. Arthritis Care Res (Hoboken). 2012;64:295\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1822_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jvs.2017.01.063","volume":"66","author":"WP Robinson","year":"2017","unstructured":"Robinson WP, Loretz L, Hanesian C, Flahive J, Bostrom J, Lunig N, et al. Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center. J Vasc Surg. 2017;66:488\u201398.","journal-title":"J Vasc Surg"},{"key":"1822_CR19","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1136\/annrheumdis-2016-209481","volume":"75","author":"Y Allanore","year":"2016","unstructured":"Allanore Y, Denton CP, Krieg T, Cornelisse P, Rosenberg D, Schwierin B, et al. Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort. Ann Rheum Dis. 2016;75:1736\u201340.","journal-title":"Ann Rheum Dis"},{"key":"1822_CR20","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/art.39718","volume":"68","author":"M Cutolo","year":"2016","unstructured":"Cutolo M, Herrick AL, Distler O, Becker MO, Beltran E, Carpentier P, et al. Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study. Arthritis Rheumatol. 2016;68:2527\u201339.","journal-title":"Arthritis Rheumatol"},{"key":"1822_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semarthrit.2017.02.006","volume":"47","author":"J Avouac","year":"2017","unstructured":"Avouac J, Lepri G, Smith V, Toniolo E, Hurabielle C, Vallet A, Amrouche F, et al. Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis. Semin Arthritis Rheum. 2017;47:86\u201394.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1822-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1822-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1822-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T19:13:32Z","timestamp":1579806812000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1822-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1822-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"6 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval of DeSScipher OT1 has been obtained from all participating centres\u2019 local ethics committees (project coordinator\u2019s ethics board: Ethics Review board of the Justus-Liebig University Giessen, Germany, approval no 02\/13; partners centres ethics review boards: University of Zurich, Switzerland; University of Paris, France; University of Florence Italy; The Second University of Naples, Italy; University of Basel, Switzerland; University College of London, United Kingdom; University of Berlin Charit\u00e9, Germany; University of P\u00e9cs, Hungary; University of Leeds, United Kingdom; and contributors centres ethics boards (additional 21 centres)). Each patient signed a written informed consent form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report personal fees and non-financial support by the European Community\u2019s Framework Program 7 [FP7-HEALTH-2012.2.4.4-2 Observational trials in rare diseases]; grant agreement no. 305495.OD: Consultancies, speaking fees, and honoraria < $10,000: AnaMar, Bayer, Boehringer Ingelheim, Catenion, CLS Behring, ChemomAb, Roche, GSK, Inventiva, Italfarmaco, Lilly, medac, Medscape, Mitsubishi Tanabe Pharma, MSD, Novartis, Pfizer, Sanofi, UCB Consultancies, speaking fees, and honoraria > $10,000: Bayer, B\u00f6hringer. Patents, licenses, or licensing fees: Patent mir-29 for the treatment of systemic sclerosis licensedCPD: Consultancies, speaking fees, and honoraria < $10,000: Actelion, Bayer, Boehringer Ingelheim, Inventiva, Sanofi-Aventis, CSL BehringSV: Consultancies, speaking fees, and honoraria < $10,000: Thermofisher, Abbvie, Boehringer-IngelheimYA: Consultancies, speaking fees, and honoraria < $10,000: Actelion, Boehringer, Roche, Sanofi, Inventiva, Medac, Bayer, BMS, PfizerMMC: Consultancies, speaking fees, and honoraria < $10,000: Actelion, BMS, Pfizer","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"35"}}